Skip to content

Quantitation of McArdle's Sign and Evaluation of Specificity for Multiple Sclerosis

Quantitation of McArdle's Sign and Evaluation of Specificity for Multiple Sclerosis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03122873
Enrollment
125
Registered
2017-04-21
Start date
2016-02-01
Completion date
2017-06-30
Last updated
2017-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Brief summary

The study is designed to quantitate McArdle's sign, an increase in measurable weakness with neck flexion described in patients with multiple sclerosis, and to determine whether it is or is not specific for multiple sclerosis.

Detailed description

Finger strength will be measure using a torque-measuring device designed to quantitate finger extension strength. The device was designed for point of treatment use, patient safety and portability. Strength will be measured in 5 paired trials, first with neck extended and then with neck flexed. Two protocols will be evaluated, one testing isometric strength against a fixed resistance and the second testing strength against dynamic resistance. McArdle's sign is the difference between strength with neck extension and strength with neck flexion. The data will be digitally registered and dynamic neck position will be recorded electronically in real time. Graphs of dynamic changes in torque versus neck position will be generated and superimposed. Strength will be quantitated using Matlab software. Consecutive patients with myelopathy of any cause with detectable finger extensor weakness will be studied, either due to MS or due to other cause of myelopathy (other inflammatory, vascular, compressive, neoplastic and other). Additionally, normal controls will be studied as will patients with finger extension weakness due to peripheral nerve lesions.

Interventions

None listed

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Myelopathy of any cause with finger extension weakness * Patients with peripheral neuropathy with finger extension weakness * Healthy controls

Exclusion criteria

* Pregnant subjects.

Design outcomes

Primary

MeasureTime frameDescription
Difference in quantitative measure of strength between extended positions of the neck and fully flexed position of the neck (McArdle's sign)through study completion, an average of 1 yearComparison of means and medians of the difference in strength in the fully extended and fully flexed positions (McArdle's sign) measured using a torque measurement device between multiple sclerosis versus other myelopathy and between multiple sclerosis and normal controls; measurements are done in 5 successive trials of extension and flexion and the mean percentage difference between extension and flexion of the last 4 trials is averaged to calculated the McArdle's sign; the goal is to determine whether there is a specific level of McArdle sign that is diagnostic for MS using receiver operator curve method.

Secondary

MeasureTime frameDescription
Relative sensitivity of clinical versus instrument-based detection of McArdle's sign.through study completion, an average of 1 yearCompare the clinical detection of the sign by the referring clinician and technician compared to the device-determined McArdle's sign

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026